Jennifer Goldsack, CEO at Digital Medicine Society
“We need to flip the script and see regulatory strategy become a differentiator for digital health solution providers. As we anticipate a tightening of funding for digital innovators, the importance of selecting optimal regulatory pathways for individual products and product portfolios becomes critically important to ensure market access, trust, and adoption.”
Join our next project
Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients